ATG7 and metabolic dysfunction-associated steatotic liver disease: Consequently, we studied the relationship between hepatic ATG7 mRNA and ATG7 protein expressions, and the presence of NAFLD comorbidities, such as dyslipidemia, type 2 diabetes mellitus, hypertension, and metabolic syndrome [41].